Literature DB >> 2929807

The role of secondary vaccine failures in measles outbreaks.

R G Mathias1, W G Meekison, T A Arcand, M T Schechter.   

Abstract

An outbreak of measles in 1985-86 in a community where measles vaccine trials had been carried out from 1974-76 allowed the assessment of the role of secondary vaccine failures in previously immunized children. A total of 188 children from the vaccine trial were followed. Of these, 175 seroconverted initially while 13 (6 per cent) required re-immunization (primary failure). A total of 13 cases of measles, eight of which were laboratory and/or physician-confirmed, were reported in this cohort. Of these, nine cases occurred in the 175 subjects who had hemagglutination inhibition test (HI) and neutralizing antibody responses following the initial immunization. These nine cases represent secondary vaccine failures. An additional four cases occurred in the 13 subjects with primary vaccine failure. We conclude that secondary vaccine failures occur and that while primary failures account for most cases, secondary vaccine failures contribute to the occurrence of measles cases in an epidemic. A booster dose of measles vaccine may be necessary to reduce susceptibility to a sufficiently low level to allow the goal of measles elimination to be achieved.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2929807      PMCID: PMC1349980          DOI: 10.2105/ajph.79.4.475

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  24 in total

1.  The future of measles in highly immunized populations. A modeling approach.

Authors:  D L Levy
Journal:  Am J Epidemiol       Date:  1984-07       Impact factor: 4.897

2.  Vaccination against rubella and measles: quantitative investigations of different policies.

Authors:  R M Anderson; R M May
Journal:  J Hyg (Lond)       Date:  1983-04

3.  Canada needs a compulsory measles vaccination program.

Authors:  J W Davies; S E Acres; P V Varughese
Journal:  Can Med Assoc J       Date:  1982-01-15       Impact factor: 8.262

4.  Measles vaccine efficacy in children previously vaccinated at 12 months of age.

Authors:  J S Marks; T J Halpin; W A Orenstein
Journal:  Pediatrics       Date:  1978-12       Impact factor: 7.124

5.  Measles vaccine efficacy: influence of age at vaccination vs. duration of time since vaccination.

Authors:  J D Shelton; J E Jacobson; W A Orenstein; K F Schulz; H D Donnell
Journal:  Pediatrics       Date:  1978-12       Impact factor: 7.124

Review 6.  Prospects for the eradication of infectious diseases.

Authors:  C Stuart-Harris
Journal:  Rev Infect Dis       Date:  1984 May-Jun

7.  Continuing measles transmission in students despite school-based outbreak control program.

Authors:  S G Wassilak; W A Orenstein; P L Strickland; C A Butler; K J Bart
Journal:  Am J Epidemiol       Date:  1985-08       Impact factor: 4.897

8.  Further-attenuated measles vaccine: characteristics and use.

Authors:  S Krugman
Journal:  Rev Infect Dis       Date:  1983 May-Jun

9.  The use of IgM tests for analysis of the causes of measles vaccine failures: experience gained in an epidemic in Hungary in 1980 and 1981.

Authors:  G Nagy; S Kósa; S Takátsy; M Koller
Journal:  J Med Virol       Date:  1984       Impact factor: 2.327

10.  Antibody response following measles-mumps-rubella vaccine under conditions of customary use.

Authors:  P A Brunell; K Weigle; M D Murphy; Z Shehab; E Cobb
Journal:  JAMA       Date:  1983-09-16       Impact factor: 56.272

View more
  36 in total

1.  Twice vaccinated recipients are better protected against epidemic measles than are single dose recipients of measles containing vaccine.

Authors:  M Paunio; H Peltola; M Valle; I Davidkin; M Virtanen; O P Heinonen
Journal:  J Epidemiol Community Health       Date:  1999-03       Impact factor: 3.710

2.  Measles eradication: is it in our future?

Authors:  W A Orenstein; P M Strebel; M Papania; R W Sutter; W J Bellini; S L Cochi
Journal:  Am J Public Health       Date:  2000-10       Impact factor: 9.308

Review 3.  Correlates of protection induced by vaccination.

Authors:  Stanley A Plotkin
Journal:  Clin Vaccine Immunol       Date:  2010-05-12

4.  Guidelines for measles control in Canada.

Authors: 
Journal:  CMAJ       Date:  1991-04-15       Impact factor: 8.262

5.  Costs and benefits of a second measles inoculation of children in Israel, the West Bank, and Gaza.

Authors:  G M Ginsberg; T H Tulchinsky
Journal:  J Epidemiol Community Health       Date:  1990-12       Impact factor: 3.710

6.  New York State's two-dose schedule for measles immunization.

Authors:  G S Birkhead; D L Morse; I J Mills; L F Novick
Journal:  Public Health Rep       Date:  1991 May-Jun       Impact factor: 2.792

7.  Statement on recommended use of measles vaccine in Canada.

Authors: 
Journal:  CMAJ       Date:  1990-08-15       Impact factor: 8.262

8.  Epidemiology of measles in Taiwan: dynamics of transmission and timeliness of reporting during an epidemic in 1988-9.

Authors:  M S Lee; C C King; C J Chen; S Y Yang; M S Ho
Journal:  Epidemiol Infect       Date:  1995-04       Impact factor: 2.451

Review 9.  The genetic basis for interindividual immune response variation to measles vaccine: new understanding and new vaccine approaches.

Authors:  Iana H Haralambieva; Inna G Ovsyannikova; V Shane Pankratz; Richard B Kennedy; Robert M Jacobson; Gregory A Poland
Journal:  Expert Rev Vaccines       Date:  2013-01       Impact factor: 5.217

10.  Revaccination of children during school-based measles outbreaks: potential impact of a new policy recommendation.

Authors:  J W Osterman; D Melnychuk
Journal:  CMAJ       Date:  1992-03-15       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.